{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT01373450: Phase 1 Interventional Completed Type 2 Diabetes Mellitus
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:mavrostobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:polzastobart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:raludotatug deruxtecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03879694: Phase 1 Interventional Recruiting Lung Atypical Carcinoid Tumor
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01395745: Phase 3 Interventional Completed Systemic Lupus Erythematosus
(2013)
Source URL:
Class:
PROTEIN